Clinical Edge Journal Scan

Salt intake is associated with higher risk for gastric cancer


 

Key clinical point: Salty taste preference, always using table salt, and a greater high-salt and salt-preserved foods intake are associated with a higher risk for gastric cancer.

Major finding: The risk for gastric cancer was higher with salty vs. tasteless taste preference (adjusted odds ratio [aOR] 1.59; 95% CI 1.25-2.03), always vs. never using table salt (aOR 1.33; 95% CI 1.16-1.54), and the highest vs. lowest tertile of high-salt and salt-preserved foods intake (aOR 1.24; 95% CI 1.01-1.51). There was no significant association for the highest vs. lowest tertile of total sodium intake (aOR 1.08; 95% CI 0.82-1.43).

Study details: This study was an individual participant data meta-analysis of 25 studies including 10,283 patients with gastric cancer and 24,643 control individuals.

Disclosures: This study was supported by Portuguese Ministry of Science, Technology, and Higher Education; Instituto de Saúde Pública da Universidade do Porto; Associazione Italiana per la Ricerca sul Cancro; and others. The authors declared no conflicts of interest.

Source: Morais S et al. Salt intake and gastric cancer: A pooled analysis within the Stomach cancer Pooling (StoP) Project. Cancer Causes Control. 2022;33:779-791 (Mar 19). Doi: 10.1007/s10552-022-01565-y

Recommended Reading

Global incidence, deaths from CRC doubled over past 3 decades
MDedge Hematology and Oncology
Better survival in older cancer patients who take metformin
MDedge Hematology and Oncology
PD-L1 test debated in gastroesophageal cancer immunotherapy
MDedge Hematology and Oncology
Gastric cancer: Function-preserving surgery fails to show noninferiority
MDedge Hematology and Oncology
HER2-negative gastric cancer: Docetaxel-based chemotherapy does not improve outcomes
MDedge Hematology and Oncology
Gastric cancer: Add-on apatinib to neoadjuvant chemotherapy shows good response
MDedge Hematology and Oncology
Gastric cancer: Perioperative capecitabine plus oxaliplatin shows good survival
MDedge Hematology and Oncology
Early gastric cancer: Undifferentiated-predominant mixed-type is more aggressive
MDedge Hematology and Oncology
Gastric cancer: Modified Glasgow prognostic score predicts sarcopenia
MDedge Hematology and Oncology
Cimetropium bromide use during endoscopy improves gastric neoplasm detection rate
MDedge Hematology and Oncology